These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3331697)

  • 1. Germ cell assays in routine mutagenicity testing.
    Müller L; Madle S; Bass R
    Mutagenesis; 1987 Jan; 2(1):69. PubMed ID: 3331697
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of gene mutations in germ cells of the mouse.
    Ehling UH
    Arch Toxicol; 1980 Nov; 46(1-2):123-38. PubMed ID: 7235989
    [No Abstract]   [Full Text] [Related]  

  • 3. Selecting chemicals and assays for assessing mammalian germ cell mutagenicity.
    Shelby MD
    Mutat Res; 1996 Jun; 352(1-2):159-67. PubMed ID: 8676905
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of somatic and germ cell models for cytogenetic screening.
    Holden HE
    J Appl Toxicol; 1982 Aug; 2(4):196-200. PubMed ID: 7185901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term and short-term screening assays for carcinogens: a critical appraisal.
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):1-426. PubMed ID: 6935176
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
    Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
    Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The place of the host-mediated assay.
    McGregor DB
    Arch Toxicol; 1980 Nov; 46(1-2):111-21. PubMed ID: 7235988
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-term assays to predict carcinogenicity. Assays for germ-cell mutations in mammals.
    Ehling UH; Chu EH; De Carli L; Evans HJ; Hayashi M; Lambert B; Neubert D; Thilly WG; Vainio H
    IARC Sci Publ; 1986; (83):245-65. PubMed ID: 3305344
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular dosimetry as a tool in genetic risk assessment.
    Aaron CS
    Birth Defects Orig Artic Ser; 1988; 24(5):53-78. PubMed ID: 3073818
    [No Abstract]   [Full Text] [Related]  

  • 10. [Permanent embryonic mouse germ cell-lines, an in vitro alternative to in vivo germ cell mutagenicity tests].
    Klemm M; Genschow E; Pohl I; Barrabas C; Liebsch M; Spielmann H
    ALTEX; 2001; 18(2):127-30. PubMed ID: 11378688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for deployment of short-term assays for evidence of carcinogenicity.
    Drake JW; de Serres FJ; Darby WJ; Dunkel VC; Longfellow DG; Ott H; Purchase IF; Ramel C; Schlatter C; Smith EM
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):295-308. PubMed ID: 6935184
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of germ cell cytogenetic tests in the regulatory process.
    Kirkland DJ
    Mutagenesis; 1987 Jan; 2(1):61-7. PubMed ID: 3331696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetical tests on mammalian cells in vitro.
    Moutschen J
    Arch Toxicol; 1980 Nov; 46(1-2):61-75. PubMed ID: 7235999
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluating the mutagenic potential of chemicals. The minimal battery and extrapolation problems.
    Sobels FH
    Arch Toxicol; 1980 Nov; 46(1-2):21-30. PubMed ID: 7235996
    [No Abstract]   [Full Text] [Related]  

  • 15. Transgenic germ cell mutation assays: a small collaborative study.
    Ashby J
    Environ Mol Mutagen; 1995; 25(1):1-3. PubMed ID: 7875121
    [No Abstract]   [Full Text] [Related]  

  • 16. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The measurement of induced genetic change in mammalian germ cells.
    Adler ID; Pacchierotti F; Russo A
    Methods Mol Biol; 2012; 817():335-75. PubMed ID: 22147580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with mutagenicity testing of new drugs: viewpoint of a regulatory agency.
    Madle S; Korte A; Bass R
    Mutat Res; 1987 Aug; 182(4):187-92. PubMed ID: 3302693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The necessity of determining the mutagenicity of new drugs].
    Bogajewski J; Schöneich J
    Pol Tyg Lek; 1982 Mar; 37(2):63-7. PubMed ID: 6750579
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations for screening for potential human germ cell mutagens: an ICPEMC Working Paper.
    Bridges BA; Mendelsohn ML
    Prog Clin Biol Res; 1986; 209B():51-65. PubMed ID: 3749105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.